FDA 483 - PEL Healthcare LLC - April 24, 2018

G&W PA Laboratories, LLC, a human drug manufacturer in Sellersville, PA, was cited for failing to thoroughly review unexplained discrepancies and out-of-specification results. The inspection revealed multiple instances of incomplete investigations into product impurities and stability issues. This indicates significant deficiencies in the firm's quality control and investigation processes.